The IVD team of Magna Pharmacia participated in the first two-day CardioImpact Summit, held in Belgrade on June 11 & 12.
During the summit, the latest trends in the application of advanced laboratory markers, smart sensors and digital technologies in the prevention, early detection and monitoring of cardiovascular diseases were presented, as well as improvements in clinical decision-making.
One of the key messages of the summit was a paradigm shift in laboratory medicine — the transition from the traditional role of the laboratory to a proactive partner in clinical practice.
Participation in such gatherings represents an important part of the continuous professional development of our team and confirms Magna Pharmacia’s commitment to following the latest achievements in the field of in vitro diagnostics.